NIH #R03CA280302
Tumor downstaging with small molecule therapeutics to enhance Uveal Melanoma metastasis eradication by B7-H3 CAR T cells
- Amount
- $100K–$200K
- Period
- 2023-09-20 → 2025-08-31
- PIs
- 1
Cristina R. Ferrone
Full Professor(heuristic)
Pancreatic and Hepatic Oncology Research · Oncology
Compare more Oncology professors.
h-index80
i10-index243
Publications733
Citations27,502
Grants
5 total · 0 active
NIH #R03CA253319
Potential role of brachyury in HLA class I antigen processing machinery component downregulation in chordoma cells
- Amount
- <$100K
- Period
- 2020-09-01 → 2024-11-30
- PIs
- 2
NIH #R03CA249542
B7-H3 CAR T cell-based immunotherapy combined with Losartan to counteract desmoplasia for the treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
- Amount
- $100K–$200K
- Period
- 2021-05-01 → 2023-04-30
- PIs
- 2
Awarded at MASSACHUSETTS GENERAL HOSPITAL
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Recent Public Signals
- New paper: Data from Distinct Malignant Cell States and Myeloid Glutamate Signaling Associated with Aggressive Pancreatic Neuroendocrine Tumors2026-06-19
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data Freshness
- Publications as of 2026-07-09
- Grants as of 2026-08-26
Data may not be current
Find elsewhere
ORCID: 0000-0002-6295-1085